Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
408.60
-6.61 (-1.59%)
Dec 10, 2025, 12:09 PM EST - Market open
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
27
Consensus Rating
Strong Buy
Price Target
$483.89
Upside
+18.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $395 → $479 | Hold | Maintains | $395 → $479 | +17.23% | Nov 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $449 → $489 | Buy | Reiterates | $449 → $489 | +19.68% | Oct 31, 2025 |
| Barclays | Barclays | Buy Maintains $460 → $527 | Buy | Maintains | $460 → $527 | +28.98% | Oct 31, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $550 → $549 | Strong Buy | Maintains | $550 → $549 | +34.36% | Oct 30, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $459 → $535 | Strong Buy | Maintains | $459 → $535 | +30.93% | Oct 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $475 → $473 | Buy | Maintains | $475 → $473 | +15.76% | Oct 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $570 | Strong Buy | Reiterates | $570 | +39.50% | Oct 10, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $405 → $475 | Hold | Maintains | $405 → $475 | +16.25% | Oct 6, 2025 |
| Stifel | Stifel | Strong Buy Maintains $441 → $495 | Strong Buy | Maintains | $441 → $495 | +21.15% | Oct 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $435 → $500 | Buy | Maintains | $435 → $500 | +22.37% | Sep 19, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $453 → $520 | Strong Buy | Maintains | $453 → $520 | +27.26% | Sep 17, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $504 → $566 | Strong Buy | Maintains | $504 → $566 | +38.52% | Sep 16, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $453 → $550 | Strong Buy | Maintains | $453 → $550 | +34.61% | Sep 15, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $280 → $515 | Buy | Maintains | $280 → $515 | +26.05% | Sep 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $450 → $470 | Buy | Maintains | $450 → $470 | +15.03% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $570 | Strong Buy | Reiterates | $570 | +39.50% | Sep 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.